CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,388.30
-70.50 (-4.83%)
At close: Jan 21, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 85.05 billion as of January 23, 2026.
Market Cap
85.05B
Enterprise Value
85.14B
Revenue
12.99B
Ranking
n/a
PE Ratio
48.59
Stock Price
1,388.30
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has decreased from 87.97B to 85.05B, a decrease of -3.32%. That is a compound annual growth rate of -27.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 85.92B | 1.44% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.52B |
| Caplin Point Laboratories | 137.79B |
| Granules India | 134.12B |
| Rubicon Research | 109.30B |
| Sanofi India | 93.47B |
| Procter & Gamble Health | 90.41B |
| Viyash Scientific | 86.88B |